{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:12:16Z","timestamp":1788419536044,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2026,8,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The structural variety and associated biological potential of pyrimidine derivatives\nhave made them attractive to medicinal chemists. Due to the various biological activities of Pyrimidine derivatives and structural derivatives of DNA, many researchers have been prompted\nto explore this area. Substituted Pyrimidine derivatives have a broad range of pharmacological\napplications, including antimicrobial, anticancer, and anti-inflammatory activities. The pyrimidine ring and its fused derivatives, which include pyrazolo[3,4-d]pyrimidine, pyrido[2,3-\nd]pyrimidine, quinazoline, and furo[2,3-d] pyrimidine, have generated a great deal of attention\ndue to the high variety of biological potential that they possess. In addition, fused pyrimidines\nare intended as bioisosteres of purines. As a result, numerous substances, including pyrimidines\nand fused pyrimidine derivatives, have demonstrated promising anticancer potential. The emergence of multidrug resistance in cancer cells has significantly reduced the effectiveness of numerous anticancer drugs, posing a challenge to cancer treatment. To avoid this issue, researchers are continuously focusing on target-based drug discovery as a promising pathway for developing novel anticancer agents with improved efficacy and selectivity. Specifically, this review\nwill explore various pyrimidine derivatives, examining positional substitutions and fusion with\nother heterocyclic rings to elucidate how these compounds interact with molecular targets involved in cancer development and progression. By understanding these interactions, researchers\ncan design more potent pyrimidine -based drugs with better target selectivity. Moreover, the review will also explain the structure-activity relationships of various pyrimidine derivatives,\nproviding insights into the structural features that contribute to their anticancer activity. In the\npast few years, numerous novel pyrimidine derivatives have been developed and studied for\ntheir anticancer activities. The primary objective of this review is to evaluate the structureactivity relationship (SAR) of pyrimidine derivatives developed as anticancer agents over the\npast decade.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734064503567260817161010","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:28:33Z","timestamp":1788107313000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pyrimidine Derivatives as Anticancer Agents: Structural Insights and SAR\nStudies"],"prefix":"10.2174","volume":"22","author":[{"given":"Balasubramanian","family":"Narasimhan","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak124001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Sapra","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak124001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064503567260817161010","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/257560\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064503567260817161010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:27Z","timestamp":1788416007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/257560\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064503567260817161010","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}